Patents by Inventor Philip Ma

Philip Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210072344
    Abstract: Example embodiments present radar units capable of operating in multiple polarizations. An example radar unit may include a set of transmission antennas and a set of reception antennas. Particularly, the transmission antennas may each be configured to transmit radar signals that radiate in one or more of four potential polarizations. The four polarizations can correspond to horizontal linear, vertical linear and slanted polarizations at approximately positive forty-five degrees and negative forty-five degrees from the horizontal plane. As such, the reception antennas of the radar unit may each be configured to receive reflected radar signals that are radiating in one of the four potential polarizations. The radar unit may further include an amplifier configured to cause one or multiple transmission antennas to selectively transmit between two or more of the four polarization channels.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Inventors: Jamal Izadian, Philip Ma
  • Publication number: 20210041528
    Abstract: Example embodiments relate to slanted radomes for protecting radar units. An example radar system may include a radar unit that includes at least one antenna having a radiation pattern. The radar unit is configured to transmit a radar signal based on the radiation pattern and receive radar signals. In addition, the radar system further includes a radome located in a direction of transmission of the radiation pattern. Particularly, the radome is aligned at an angle relative to a plane of the at least one antenna such that reflections of the transmitted radar signal caused by the radome are directed towards at least one of a null of the radiation pattern and an absorption component.
    Type: Application
    Filed: August 6, 2019
    Publication date: February 11, 2021
    Inventors: Benjamin Chen, Adam Brown, Philip Ma, Matthew Markel
  • Patent number: 10852390
    Abstract: Example embodiments present radar units capable of operating in multiple polarizations. An example radar unit may include a set of transmission antennas and a set of reception antennas. Particularly, the transmission antennas may each be configured to transmit radar signals that radiate in one or more of four potential polarizations. The four polarizations can correspond to horizontal linear, vertical linear and slanted polarizations at approximately positive forty-five degrees and negative forty-five degrees from the horizontal plane. As such, the reception antennas of the radar unit may each be configured to receive reflected radar signals that are radiating in one of the four potential polarizations. The radar unit may further include an amplifier configured to cause one or multiple transmission antennas to selectively transmit between two or more of the four polarization channels.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: December 1, 2020
    Assignee: Waymo LLC
    Inventors: Jamal Izadian, Philip Ma
  • Publication number: 20190187247
    Abstract: Example embodiments present radar units capable of operating in multiple polarizations. An example radar unit may include a set of transmission antennas and a set of reception antennas. Particularly, the transmission antennas may each be configured to transmit radar signals that radiate in one or more of four potential polarizations. The four polarizations can correspond to horizontal linear, vertical linear and slanted polarizations at approximately positive forty-five degrees and negative forty-five degrees from the horizontal plane. As such, the reception antennas of the radar unit may each be configured to receive reflected radar signals that are radiating in one of the four potential polarizations. The radar unit may further include an amplifier configured to cause one or multiple transmission antennas to selectively transmit between two or more of the four polarization channels.
    Type: Application
    Filed: December 20, 2017
    Publication date: June 20, 2019
    Inventors: Jamal Izadian, Philip Ma
  • Publication number: 20070027186
    Abstract: A novel process and intermediates thereof for making 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones of the type shown below from appropriate phenyl hydrazines is described. These compounds are useful as factor Xa inhibitors.
    Type: Application
    Filed: September 7, 2006
    Publication date: February 1, 2007
    Inventors: Jiacheng Zhou, Lynette Oh, Philip Ma, Hui-Yin Li, Pasquale Confalone
  • Patent number: 7153960
    Abstract: A novel process and intermediates thereof for making 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones of the type shown below from appropriate phenyl hydrazines is described. These compounds are useful as factor Xa inhibitors.
    Type: Grant
    Filed: June 8, 2005
    Date of Patent: December 26, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jiacheng Zhou, Lynette M. Oh, Philip Ma, Hui-Yin Li, Pasquale Confalone
  • Patent number: 7112679
    Abstract: The present invention relates to processes for the production of ?-aryl-?-ketonitriles, which serve as synthetic intermediates in the preparation of a series of biologically important molecules such as corticotropin releasing factor (CRF) receptor antagonists.
    Type: Grant
    Filed: February 25, 2004
    Date of Patent: September 26, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jiacheng Zhou, Lynette May Oh, Philip Ma
  • Publication number: 20050245566
    Abstract: A novel process and intermediates thereof for making 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones of the type shown below from appropriate phenyl hydrazines is described. These compounds are useful as factor Xa inhibitors.
    Type: Application
    Filed: June 8, 2005
    Publication date: November 3, 2005
    Inventors: Jiacheng Zhou, Lynette Oh, Philip Ma, Hui-Yin Li, Pasquale Confalone
  • Patent number: 6919451
    Abstract: A novel process and intermediates thereof for making 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones of the type shown below from appropriate phenyl hydrazines is described. These compounds are useful as factor Xa inhibitors.
    Type: Grant
    Filed: December 3, 2002
    Date of Patent: July 19, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jiacheng Zhou, Lynette M. Oh, Philip Ma, Hui-Yin Li, Pasquale Confalone
  • Publication number: 20040171829
    Abstract: The present invention relates to processes for the production of &agr;-aryl-&bgr;-ketonitriles, which serve as synthetic intermediates in the preparation of a series of biologically important molecules such as corticotropin releasing factor (CRF) receptor antagonists.
    Type: Application
    Filed: February 25, 2004
    Publication date: September 2, 2004
    Applicant: Bristol-Myers Squibb Pharma Company
    Inventors: Jiacheng Zhou, Lynette May Oh, Philip Ma
  • Patent number: 6727360
    Abstract: The present invention relates to processes for the production of &agr;-aryl-&bgr;-ketonitriles, which serve as synthetic intermediates in the preparation of a series of biologically important molecules such as corticotropin releasing factor (CRF) receptor antagonists.
    Type: Grant
    Filed: March 13, 2003
    Date of Patent: April 27, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Jiacheng Zhou, Lynette May Oh, Philip Ma
  • Patent number: 6722891
    Abstract: A magnetic drawing apparatus including image forming means, image erasing means, motion generating means, movement control means and a main housing, wherein: the image forming means include a plurality of magnetic cells which collectively define an image forming surface, the magnetic cell contains a viscous fluid and magnetic powder; the image erasing means include a magnetic image eraser which is adjacent to the image forming means, the magnetic image eraser is connected to the motion generating means and is movable relative to the image forming means; and the movement control means include means for actuating the motion generating means and means for selecting the direction of movement of the magnetic image eraser with respect to the image forming means.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: April 20, 2004
    Assignee: Goldlok Toys Manufactory Co., Ltd.
    Inventor: Philip Ma
  • Publication number: 20030208068
    Abstract: The present invention relates to processes for the production of &agr;-aryl-&bgr;-ketonitriles, which serve as synthetic intermediates in the preparation of a series of biologically important molecules such as corticotropin releasing factor (CRF) receptor antagonists.
    Type: Application
    Filed: March 13, 2003
    Publication date: November 6, 2003
    Inventors: Jiacheng Zhou, Lynette May Oh, Philip Ma
  • Publication number: 20030181466
    Abstract: A novel process and intermediates thereof for making 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones of the type shown below from appropriate phenyl hydrazines is described.
    Type: Application
    Filed: December 3, 2002
    Publication date: September 25, 2003
    Inventors: Jiacheng Zhou, Lynette M. Oh, Philip Ma, Hui-Yin Li, Pasquale Confalone
  • Patent number: 6624311
    Abstract: The present invention relates to a process for the enantioselective enzymatic aminolysis of racemic 2-[3-(4-cyanophenyl)-4,5-dihydro-5-isoxazolyl]acetate ((R/S)-I) by methyl N&agr;-Boc-L-&agr;,&bgr;-diaminoproprionate.p-toluenesulfonic acid. More specifically, this invention pertains to a process for the enantioselective enzymatic aminolysis of racemic isobutyl 2-[3-(4-cyanophenyl)-4,5-dihydro-5-isoxazolyl]-acetate by methyl N&agr;-Boc-L-&agr;,&bgr;-diaminoproprionate.p-toluene sulfonic acid to produce (R)-methyl-3-[[[3-(4-cyanophenyl)-4,5-dihydro-5-isoxazolyl]acetyl]amino]-N-(butoxycarbonyl)-L-alanine, an intermediate in the preparation of roxifiban, an isoxazoline-based platelet glycoprotein IIb/IIIa antagonist which has activity as an antithrombotic agent.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: September 23, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Robert DiCosimo, Philip Ma, Jaan A. Pesti
  • Patent number: 6610858
    Abstract: The present invention relates to processes for the conversion of nitriles to amidines in the preparation of compounds which are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex. The compounds described herein are potent thrombolytics and useful for the inhibition of platelet aggregation in the treatment of thromboembolic disorders.
    Type: Grant
    Filed: April 25, 2002
    Date of Patent: August 26, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Philip Ma, Pasquale N. Confalone, Hui-Yin Li
  • Patent number: 6562965
    Abstract: The present invention relates to processes for the production of &agr;-aryl-&bgr;-ketonitriles, which serve as synthetic intermediates in the preparation of a series of biologically important molecules such as corticotropin releasing factor (CRF) receptor antagonists.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: May 13, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Jiacheng Zhou, Lynette May Oh, Philip Ma
  • Patent number: D812777
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: March 13, 2018
    Assignee: Volvo Lastvagnar AB
    Inventors: Philip Ma, Brian Balicki
  • Patent number: D842785
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: March 12, 2019
    Assignee: VOLVO LASTVAGNAR AB
    Inventors: Brian Balicki, Philip Ma, Dwayne Patterson
  • Patent number: D886013
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: June 2, 2020
    Assignee: VOLVO LASTVAGNAR AB
    Inventors: Philip Ma, Brian Balicki